ClinicalTrials.Veeva

Menu

Effect of Fetuin A in Hemodialysis Patients

U

University of Shizuoka

Status

Unknown

Conditions

Hemodialysis
Malnutrition

Study type

Observational

Funder types

Other

Identifiers

NCT00309426
CT2006003

Details and patient eligibility

About

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

Full description

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

Sex

All

Ages

Under 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hemodialysis for at least 6 months

Exclusion criteria

  • Disabled patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems